Dr. David S. Meinbach, MD

Dr. Meinbach practices at Urology Group of Florida in Delray Beach, Florida.

Dr. Meinbach's NPI, 1962596445, was assigned on October 2, 2006. Dr. Meinbach graduated from University of Miami, Miller School of Medicine in 2001. Dr. Meinbach holds Florida license ME0088959.

Dr. Meinbach's primary practice is Urology Group of Florida, at 5350 W Atlantic Ave, Delray Beach, FL 33484 in Palm Beach County. The practice phone is (561) 496-4444.

Dr. Meinbach's primary practice is Urology Group of Florida in Delray Beach, Florida. Dr. Meinbach is also affiliated with Boca Raton Regional Hospital. The medical group on file is Urology Group of Florida. Dmand AI also links Dr. Meinbach to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meinbach practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Meinbach's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Meinbach is board certified in urology by the American Board of Urology. Dmand AI has Dr. Meinbach's licenses on file in 2 states: Florida and Alabama.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Meinbach treats.

CMS data shows 8,012 Medicare services from Dr. Meinbach across 37 procedure codes in 2024, for 1,216 Medicare patients. Medicare paid $417,388 for them.

CMS counts 1,216 Medicare patients who saw Dr. Meinbach in 2024. The largest group is 75 to 84, with 572 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Meinbach's median patient age at 74, with 25% women.

In 2024, Dr. Meinbach wrote 3,158 Medicare Part D claims for 818 patients. 86% of them were for generic drugs. CMS names the drug for 2,979 of them, across 30 drugs with 11 or more claims each, at $1,026,521 in total drug cost. In 2023, CMS named 2,671 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Meinbach for performance year 2024, reported individually. Dr. Meinbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meinbach as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Meinbach. Dr. Meinbach has published most often in Urology. Dr. Meinbach's most frequent co-authors are Alan Mark Nieder, Mark S. Soloway, MD and Pablo Gomez, MD.

CMS Open Payments shows 459 general payments to Dr. Meinbach from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Astellas Pharma US Inc paid the most, $1,487.

Dmand AI lists 1 award for Dr. Meinbach.

Dr. Meinbach graduated from University of Miami, Miller School of Medicine in 2001. Dr. Meinbach is a member of ACS.

Dr. Meinbach is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.